Literature DB >> 17020674

[The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].

Ignacio Alberca, Ma Soledad Asuero, José L Bóveda, Nelly Carpio, Enric Contreras, Enrique Fernández-Mondéjar, Alejandro Forteza, José A García-Erce, Abelardo García de Lorenzo, Carmen Gomar, Aurelio Gómez, Juan V Llau, María F López-Fernández, Victoria Moral, Manuel Muñoz, José A Páramo, Pablo Torrabadella, Manuel Quintana, Calixto Sánchez.   

Abstract

The Consensus Document on Alternatives to Allogenic Blood Transfusion (AABT) has been drawn up by a panel of experts from 5 scientific societies. The Spanish Societies of Anesthesiology (SEDAR), Critical Care Medicine and Coronary Units (SEMICYUC), Hematology and Hemotherapy (AEHH), Blood Transfusion (SETS) and Thrombosis and Hemostasis (SETH) have sponsored and participated in this Consensus Document. Alternatives to blood transfusion have been divided into pharmacological and non-pharmacological, with 4 modules and 12 topics. The main objective variable was the reduction of allogenic blood transfusions and/or the number of transfused patients. The extent to which this objective was achieved by each AABT was evaluated using the Delphi method, which classifies the grade of recommendation from A (supported by controlled studies) to E (non-controlled studies and expert opinion). The experts concluded that most of the indications for AABT were based on middle or low grades of recommendation, "C", "D", or "E", thus indicating the need for further controlled studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020674     DOI: 10.1157/13093075

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  5 in total

1.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

2.  Restrictive transfusion triggers in major orthopaedic surgery: effective and safe?

Authors:  Manuel Muñoz; Santiago Ramón Leal-Noval
Journal:  Blood Transfus       Date:  2013-02-06       Impact factor: 3.443

Review 3.  Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases.

Authors:  José Antonio García-Erce; Fernando Gomollón; Manuel Muñoz
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

4.  The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?

Authors:  Antonio Liras
Journal:  Int Arch Med       Date:  2008-06-23

Review 5.  [Anemia and transfusion therapy: an update].

Authors:  Z Madrazo-González; A García-Barrasa; L Rodríguez-Lorenzo; A Rafecas-Renau; G Alonso-Fernández
Journal:  Med Intensiva       Date:  2010-05-18       Impact factor: 2.491

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.